Psychological Treatment of Comorbid Insomnia and Depression: A Double-Blind Randomized Placebo-Controlled Trial

被引:6
|
作者
Blom, Kerstin [1 ,2 ]
Forsell, Erik [1 ,2 ]
Hellberg, Monica [2 ]
Svanborg, Cecilia [1 ,2 ]
Jernelov, Susanna [1 ,2 ,3 ]
Kaldo, Viktor [1 ,2 ,4 ]
机构
[1] Karolinska Inst, Ctr Psychiat Res, Dept Clin Neurosci, Stockholm, Sweden
[2] Stockholm Hlth Care Serv, Stockholm, Sweden
[3] Karolinska Inst, Dept Clin Neurosci, Div Psychol, Stockholm, Sweden
[4] Linnaeus Univ, Fac Hlth & Life Sci, Dept Psychol, Vaxjo, Sweden
关键词
Insomnia; Depression; Comorbidity; Psychological treatment; Randomized controlled trial; COGNITIVE-BEHAVIORAL THERAPY; SLEEP RESTRICTION THERAPY; SELF-HELP; DSM-IV; MAJOR DEPRESSION; SOCIAL ANXIETY; FOLLOW-UP; CBT-I; METAANALYSIS; PHARMACOTHERAPY;
D O I
10.1159/000536063
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Introduction: Insomnia and depression are highly prevalent disorders and commonly occur together. Cognitive behavioral therapy for insomnia, CBT-I, has been shown to be effective in treating insomnia and also comorbid depression. However, it is unclear whether effects of CBT-I on depression are specific or nonspecific. Also, depressive symptoms often remain too high after CBT-I, indicating a need for improved treatments. The objective was to determine whether combining CBT-I with CBT for depression, without increasing treatment length, reduces both insomnia and depression more than CBT for depression with a placebo insomnia intervention. Methods: A 12-week double-blind randomized controlled trial with a 6-month follow-up in a psychiatric setting using therapist-guided internet-delivered treatments was conducted. Patients (N = 126) were diagnosed with insomnia disorder and major depression by physicians. Primary outcome measures were as follows: self-rating scales Insomnia Severity Index (ISI) and Montgomery-angstrom sberg Depression Rating Scale (MADRS-S). Results: The combined treatment showed specific effects on insomnia severity over the control treatment (p = 0.007) but was not more effective in reducing depression severity. Within-group effects (Cohen's d) at post and at 6 months were as follows: ISI 1.40 and 1.42 (combined treatment), 0.95 and 1.00 (control); MADRS-S 0.97 and 1.12 (combined), 0.88 and 0.89 (control). Conclusions: CBT-I shows large specific effects on insomnia severity and is superior to control in this regard. Both treatments had similar effects on depression severity, i.e., combining CBT-I with CBT for depression did not enhance outcomes on depression compared to control. We suggest CBT-I should always be offered to patients with insomnia and depression comorbidity, possibly as the first-hand choice. Combining it with a psychological treatment for depression could be too burdening and may not be beneficial.
引用
收藏
页码:100 / 113
页数:14
相关论文
共 50 条
  • [21] A randomized, double-blind, placebo-controlled trial of creatine monohydrate as adjunctive treatment for bipolar depression
    Toniolo, R. A.
    Silva, M.
    Fernandes, F. B. F.
    Amaral, J. A. M. S.
    Dias, R. S.
    Lafer, B.
    BIPOLAR DISORDERS, 2017, 19 : 152 - 153
  • [22] Effects of Methylphenidate on Fatigue and Depression: A Randomized, Double-Blind, Placebo-Controlled Trial
    Kerr, Christopher W.
    Drake, Julie
    Milch, Robert A.
    Brazeau, Daniel A.
    Skretny, Judith A.
    Brazeau, Gayle A.
    Donnelly, James P.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2012, 43 (01) : 68 - 77
  • [23] Levetiracetam in the Management of Bipolar Depression: A Randomized, Double-Blind, Placebo-Controlled Trial
    Saricicek, Aybala
    Maloney, Kathleen
    Muralidharan, Anjana
    Ruf, Barbara
    Blumberg, Hilary P.
    Sanacora, Gerard
    Lorberg, Boris
    Pittman, Brian
    Bhagwagar, Zubin
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (06) : 744 - 750
  • [24] A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression
    Emslie, GJ
    Rush, AJ
    Weinberg, WA
    Kowatch, RA
    Hughes, CW
    Carmody, T
    Rintelmann, J
    ARCHIVES OF GENERAL PSYCHIATRY, 1997, 54 (11) : 1031 - 1037
  • [25] Double-blind randomized placebo-controlled trial of sibutramine
    Bray, GA
    Ryan, DH
    Gordon, D
    Heidingsfelder, S
    Cerise, F
    Wilson, K
    OBESITY RESEARCH, 1996, 4 (03): : 263 - 270
  • [26] TREATMENT OF INSOMNIA WITH TEMAZEPAM - DOUBLE-BLIND, PLACEBO-CONTROLLED EVALUATION
    CUANANG, JR
    LIMOS, L
    CLINICAL THERAPEUTICS, 1982, 4 (05) : 402 - 412
  • [27] A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence
    Kampman, Kyle M.
    Pettinati, Helen M.
    Lynch, Kevin G.
    Spratt, Kelly
    Wierzbicki, Michael R.
    O'Brien, Charles P.
    DRUG AND ALCOHOL DEPENDENCE, 2013, 133 (01) : 94 - 99
  • [28] A placebo-controlled double-blind randomized study of venlafaxine in the treatment of depression in dementia
    de Vasconcelos Cunha, Ulisses Gabriel
    Rocha, Fabio Lopes
    de Melo, Rodrigo Avila
    Valle, Estevao Alves
    de Souza Neto, Jose Julio
    Brega, Rodrigo Mendes
    Scoralick, Francisca Magalhaes
    Silva, Silvana Araujo
    de Oliveira, Flaviana Martins
    da Costa Junior, Antonio Luciano
    Faria Alves, Viviane Xavier
    Sakurai, Emilia
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2007, 24 (01) : 36 - 41
  • [29] Applicability of Press Needles to a Double-blind Trial A Randomized, Double-blind, Placebo-controlled Trial
    Miyazaki, Shougo
    Hagihara, Akihito
    Kanda, Ryo
    Mukaino, Yoshito
    Nobutomo, Koichi
    CLINICAL JOURNAL OF PAIN, 2009, 25 (05): : 438 - 444
  • [30] Metyrapone as additive treatment in major depression - A double-blind and placebo-controlled trial
    Jahn, H
    Schick, M
    Kiefer, F
    Kellner, M
    Yassouridis, A
    Wiedemann, K
    ARCHIVES OF GENERAL PSYCHIATRY, 2004, 61 (12) : 1235 - 1244